Psychotic Depression Therapeutics - Pipeline Assessment

and Market Forecasts to 2019

On 1stDecember 2014

Summary
The industry analysis specialist, has released its new report, Psychotic Depression
Therapeutics - Pipeline Assessment and Market Forecasts to 2019. The report is an essential
source of information and analysis on the global Psychotic Depression Therapeutics market. The
report identifies the key trends shaping and driving the global Psychotic Depression
Therapeutics market. The report also provides insights on the prevalent competitive landscape
and the emerging players expected to significantly alter the market positioning of the current
market leaders. Most importantly, the report provides valuable insights on the pipeline
products within the global Psychotic Depression Therapeutics sector. This report is built using
data and information sourced from proprietary databases, primary and secondary research and
in-house analysis by GlobalDatas team of industry experts.

You can buy this Report @ http://www.jsbmarketresearch.com/healthcaremedical/r-psychotic-depression-therapeutics-pipeline-assessment-and-marketforecasts-135216

Scope
The report provides information on the key drivers and challenges of the Psychotic Depression
Therapeutics market. Its scope includes Email ID- contact@jsbmarketresearch.com
Tel No- 91 2241236650
Published by- http:/www.jsbmarketresearch.com/

- Annualized seven key markets (US, France, Germany, Italy, Spain, UK and Japan) Psychotic
Depression Therapeutics market revenues data from 2006 to 2011, forecast for eight years to
2019.
- Pipeline analysis data providing a split across the different phases, mechanisms of action being
developed and emerging trends by seven key markets. Pipeline candidates fall under major
therapeutic classes.
- Analysis of the current and future competition in the seven key countries Psychotic
Depression Therapeutics market.
- Insightful review of the key industry drivers, restraints and challenges. Each trend is
independently researched to provide a qualitative analysis of its implications.
- Key topics covered include strategic competitor assessment, market characterization, unmet
needs and the implications for the Psychotic Depression Therapeutics market.
- Analysis of key recent licensing and partnership agreements in Psychotic Depression
Therapeutics market

Reasons to buy
The report will enhance your decision making capability. It will allow you to - Develop and design your in-licensing and out-licensing strategies through a review of pipeline
products and technologies and by identifying the companies with the most robust pipeline.
- Develop business strategies by understanding the trends shaping and driving the global
Psychotic Depression Therapeutics market.
- Drive revenues by understanding the key trends, innovative products and technologies,
market segments and companies likely to impact the global Psychotic Depression Therapeutics
market in future.
- Formulate effective sales and marketing strategies by understanding the competitive
landscape and by analyzing the performance of various competitors.
- Identify emerging players with potentially strong product portfolios and create effective
counter-strategies to gain a competitive advantage.
- Organize your sales and marketing efforts by identifying the market categories and segments
that present maximum opportunities for consolidations, investments and strategic
partnerships.
Email ID- contact@jsbmarketresearch.com
Tel No- 91 2241236650
Published by- http:/www.jsbmarketresearch.com/

- Whats the next big thing in the global Psychotic Depression Therapeutics market landscape?
Identify, understand and capitalize.

Other industries we cover:

Advertising and Media

Automotive and Parts
Consumer Goods
Healthcare and Medical
Finance and Banking
Food and Beverages
Travel and Tourism
Textiles and Clothing
SWOT Analysis

Discounts on Market Research Reports till 31st December, 2014

For more inquiries, contact at +91 - 998 729 5242 /
contact@jsbmarketresearch.com

Table of Content
2 Psychotic Depression Therapeutics - Introduction
2.1 Disease Overview
2.2 Epidemiology
2.2.1 Prevalence
2.2.2 Quality of Life
2.2.3 Economic Burden
2.2.4 Mortality
2.3 Etiology and Pathophysiology
2.4 Signs and Symptoms
Email ID- contact@jsbmarketresearch.com
Tel No- 91 2241236650
Published by- http:/www.jsbmarketresearch.com/

2.5 Diagnosis
2.5.1 DSM-IV-TR Diagnostic Criteria for Major Depressive Episode
2.5.2 DSM-IV-TR Diagnostic Criteria for Major Depressive Episode, Severe with Psychotic
Features
2.5.3 Rating Scales
2.6 Treatment and Management Options
2.6.1 Electroconvulsive Therapy (ECT)
2.6.2 Pharmacotherapy
2.6.3 Other Treatments
2.7 Limitation for Study of Psychotic Depression
2.8 Referral Pathway
2.9 GlobalData Pipeline Report Guidance
3 Psychotic Depression Therapeutics - Market Characterization
3.1 Overview
3.2 Psychotic Depression Therapeutics Market Size (2006-2011) - Global
3.3 Psychotic Depression Therapeutics Market Forecast (2011-2019) - Global
3.4 Psychotic Depression Therapeutics Market Size (2006-2011) - The US
3.5 Psychotic Depression Therapeutics Market Forecast (2011-2019) - The US
3.6 Psychotic Depression Therapeutics Market Size (2006-2011) - France
3.7 Psychotic Depression Therapeutics Market Forecast (2011-2019) - France
3.8 Psychotic Depression Therapeutics Market Size (2006-2011) - Germany
3.9 Psychotic Depression Therapeutics Market Forecast (2011-2019) - Germany
3.10 Psychotic Depression Therapeutics Market Size (2006-2011) - Italy
3.11 Psychotic Depression Therapeutics Market Forecast (2011-2019) - Italy
3.12 Psychotic Depression Therapeutics Market Size (2006-2011) - Spain
3.13 Psychotic Depression Therapeutics Market Forecast (2011-2019) - Spain
3.14 Psychotic Depression Therapeutics Market Size (2006-2011) - The UK
3.15 Psychotic Depression Therapeutics Market Forecast (2011-2019) - The UK
3.16 Psychotic Depression Therapeutics Market Size (2006-2011) - Japan
3.17 Psychotic Depression Therapeutics Market Forecast (2011-2019) - Japan
3.18 Drivers and Barriers for the Psychotic Depression Therapeutics Market
3.18.1 Drivers for the Psychotic Depression Therapeutics Market
3.18.2 Barriers for the Psychotic Depression Therapeutics Market
3.19 Opportunity and Unmet Need Analysis
3.20 Key Takeaway
4 Psychotic Depression Therapeutics - Competitive Assessment
4.1 Overview
4.2 Strategic Competitor Assessment
4.3 Product Profiles for the Major Off-label Marketed Products in the Psychotic Depression
Email ID- contact@jsbmarketresearch.com
Tel No- 91 2241236650
Published by- http:/www.jsbmarketresearch.com/

Market
4.3.1 Antidepressants
4.3.2 Antipsychotics
4.3.3 Mood Stabilizers (Lithium)
4.4 Key Takeaway
5 Psychotic Depression Therapeutics - Pipeline Assessment
5.1 Overview
5.2 Strategic Pipeline Assessment
5.3 Psychotic Depression Therapeutics Pipeline - Pipeline by Phases of Development
5.3.1 Psychotic Depression Therapeutics - Phase III Pipeline
5.4 Psychotic Depression Therapeutics Market - Pipeline by Mechanism of Action
5.5 Technology Trends Analytic Framework
5.6 Molecule Profile for Promising Drug Under Development
5.6.1 Korlym (mifepristone)
5.7 Key Takeaway
6 Psychotic Depression Therapeutics - Clinical Trials Mapping
6.1 Clinical Trials by Region/Country (US, EU5 and Japan)
6.2 Clinical Trials by Phase
6.3 Clinical Trials by Trial Status
6.4 Overall Sponsors
6.5 Prominent Sponsors
6.6 Top Companies Participating in Psychotic Depression Therapeutics Clinical Trials
7 Strategic Assessment
7.1 Key Events Impacting the Future Market
7.2 Psychotic Depression Therapeutics - Implications for Future Market Competition
8 Psychotic Depression Therapeutics - Future Players
8.1 Introduction
8.2 Company Profiles
8.2.1 Corcept Therapeutics Incorporated
9 Psychotic Depression Therapeutics - Appendix
9.1 Market Definitions
9.2 Abbreviations
9.3 Methodology
9.3.1 Coverage
9.3.2 Secondary Research
9.3.3 Forecasting
9.3.4 Primary Research
9.3.5 Expert Panel Validation
9.4 Contact Us
Email ID- contact@jsbmarketresearch.com
Tel No- 91 2241236650
Published by- http:/www.jsbmarketresearch.com/

9.5 Disclaimer
9.6 Bibliography

List Of Tables
Table 1: Psychotic Depression Therapeutics Market, Global, Revenue ($m), 2006-2011
Table 2: Psychotic Depression Therapeutics Market, Global, Forecast ($m), 2011-2019
Table 3: Psychotic Depression Therapeutics Market, The US, Revenue ($m), 2006-2011
Table 4: Psychotic Depression Therapeutics Market, The US, Forecast ($m), 2011-2019
Table 5: Psychotic Depression Therapeutics Market, France, Revenue ($m), 2006-2011
Table 6: Psychotic Depression Therapeutics Market, France, Forecast ($m), 2011-2019
Table 7: Psychotic Depression Therapeutics Market, Germany, Revenue ($m), 2006-2011
Table 8: Psychotic Depression Therapeutics Market, Germany, Forecast ($m), 2011-2019
Table 9: Psychotic Depression Therapeutics Market, Italy, Revenue ($m), 2006-2011
Table 10: Psychotic Depression Therapeutics Market, Italy, Forecast ($m), 2011-2019
Table 11: Psychotic Depression Therapeutics Market, Spain, Revenue ($m), 2006-2011
Table 12: Psychotic Depression Therapeutics Market, Spain, Forecast ($m), 2011-2019
Table 13: Psychotic Depression Therapeutics Market, The UK, Revenue ($m), 2006-2011
Table 14: Psychotic Depression Therapeutics Market, The UK, Forecast ($m), 2011-2019
Table 15: Psychotic Depression Therapeutics Market, Japan, Revenue ($m), 2006-2011
Table 16: Psychotic Depression Therapeutics Market, Japan, Forecast ($m), 2011-2019
Table 17: Psychotic Depression Therapeutics, Phase III Pipeline, 2011
Table 18: Psychotic Depression Therapeutics, Clinical Trials by Country, 2011
Table 19: Psychotic Depression Therapeutics, Clinical Trials by Phase, 2011
Table 20: Psychotic Depression Therapeutics, Clinical Trials by Status of Development, 2011
Table 21: Psychotic Depression Therapeutics, Clinical Trials by Overall Sponsors, 2011
Table 22: Psychotic Depression Therapeutics, Prominent Sponsors, 2011
Table 23: Psychotic Depression Therapeutics, Top Companies Participating in Therapeutics
Clinical Trials, 2011
Table 24: Corcept Therapeutics Incorporated - Pipeline, 2011
Table 25: Corcept Therapeutics Incorporated - Psychotic Depression Pipeline, 2011

List Of Figures
Figure 1: DSM-IV-TR Diagnostic Criteria for Major Depressive Episode
Figure 2: DSM-IV-TR Diagnostic Criteria for Major Depressive Episode, Severe with Psychotic
Email ID- contact@jsbmarketresearch.com
Tel No- 91 2241236650
Published by- http:/www.jsbmarketresearch.com/

Features
Figure 3: Treatment Algorithm for Psychotic Depression
Figure 4: Psychotic Depression Therapeutics - Referral Pathway
Figure 5: Psychotic Depression Therapeutics Market, Global, Revenue ($m), 2006-2011
Figure 6: Psychotic Depression Therapeutics Market, Global, Forecast ($m), 2011-2019
Figure 7: Psychotic Depression Therapeutics Market, The US, Revenue ($m), 2006-2011
Figure 8: Psychotic Depression Therapeutics Market, The US, Forecast ($m), 2011-2019
Figure 9: Psychotic Depression Therapeutics Market, France, Revenue ($m), 2006-2011
Figure 10: Psychotic Depression Therapeutics Market, France, Forecast ($m), 2011-2019
Figure 11: Psychotic Depression Therapeutics Market, Germany, Revenue ($m), 2006-2011
Figure 12: Psychotic Depression Therapeutics Market, Germany, Forecast ($m), 2011-2019
Figure 13: Psychotic Depression Therapeutics Market, Italy, Revenue ($m), 2006-2011
Figure 14: Psychotic Depression Therapeutics Market, Italy, Forecast ($m), 2011-2019
Figure 15: Psychotic Depression Therapeutics Market, Spain, Revenue ($m), 2006-2011
Figure 16: Psychotic Depression Therapeutics Market, Spain, Forecast ($m), 2011-2019
Figure 17: Psychotic Depression Therapeutics Market, The UK, Revenue ($m), 2006-2011
Figure 18: Psychotic Depression Therapeutics Market, The UK, Forecast ($m), 2011-2019
Figure 19: Psychotic Depression Therapeutics Market, Japan, Revenue ($m), 2006-2011
Figure 20: Psychotic Depression Therapeutics Market, Japan, Forecast ($m), 2011-2019
Figure 21: Psychotic Depression Therapeutics, Strategic Competitor Assessment, 2011
Figure 22: Psychotic Depression Therapeutics, Technology Trends Analytics Framework, 2011
Figure 23: Psychotic Depression Therapeutics, Technology Trends Analytics Framework,
Description, 2011
Figure 24: Structure of Korlym
Figure 25: Psychotic Depression Therapeutics, Clinical Trials by Country, 2011
Figure 26: Psychotic Depression Therapeutics, Clinical Trials by Status of Development (%), 2011
Figure 27: Psychotic Depression Therapeutics Market, Drivers and Restraints, 2011
Figure 28: Implications for Future Market Competition in the Psychotic Depression Market,
2011
Figure 29: Psychotic Depression Therapeutics Market, Pipeline by Company, 2011
Figure 30: GlobalData Market Forecasting Model

Email ID- contact@jsbmarketresearch.com

Tel No- 91 2241236650
Published by- http:/www.jsbmarketresearch.com/

Report Price:
Licence Type

Price

PDF

$ 3995

Site Licence

$ 7990

Enterprise Wide Licence

$ 11985

Related Reports:
Social Anxiety Disorders (SAD) Therapeutics - Pipeline Assessment and Market Forecasts to 2019
Polycystic Kidney Disease (PKD) Therapeutics - Pipeline Assessment and Market Forecasts to 2019
Addisons Disease (Primary or Chronic Adrenal Insufficiency) Therapeutics - Pipeline Assessment and
Market Forecasts to 2019
Obsessive Compulsive Disorder (OCD) Therapeutics - Pipeline Assessment and Market Forecasts to
2019
Traumatic Brain Injury Therapeutics - Pipeline Assessment and Market Forecasts to 2019
Osteoarthritis (OA) Pain Therapeutics - Pipeline Assessment and Market Forecasts to 2019
Posttraumatic Stress Disorder Therapeutics (PTSD) - Pipeline Assessment and Market Forecasts to
2019
Acute Spinal Cord Injury (ASCI) Therapeutics - Pipeline Assessment and Market Forecasts to 2019
Amnesia Therapeutics - Pipeline Assessment and Market Forecasts to 2019
Cancer Vaccines - Pipeline Assessment and Market Forecasts to 2018

Email ID- contact@jsbmarketresearch.com

Tel No- 91 2241236650
Published by- http:/www.jsbmarketresearch.com/

You can order this report by calling on +91 - 998 7295 242 or mail us
your contact details at contact@jsbmarketresearch.com

About JSB Market Research:JSB market research is a leading player in the market of research report distribution. It is onestop-shop for all information related to market research for any sector of the industry. Along
with providing in-depth analysis though reports, JSB market research also provides regular
updates of the market though newsletters. Our reports are a well-researched work of market
researchers with an extensive knowledge and a good level of market experience.

To know more on Psychotic Depression Therapeutics - Pipeline Assessment and

Market Forecasts to 2019
http://www.jsbmarketresearch.com/healthcare-medical/r-psychoticdepression-therapeutics-pipeline-assessment-and-market-forecasts-135216

Email ID- contact@jsbmarketresearch.com

Tel No- 91 2241236650
Published by- http:/www.jsbmarketresearch.com/